Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected	Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Not yet recruiting	Phase 1	2026-09-18		NCT06613789

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Access to Advanced Health Institute (AAHI)	1
Fred Hutchinson Cancer Center	123
HIV Vaccine Trials Network	2
National Institute of Allergy and Infectious Diseases (NIAID)	402

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Soweto HVTN CRS	Soweto	South Africa	1